• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UGT1A6 基因多态性与癫痫患者丙戊酸钠诱导性震颤的相关性。

Association of UGT1A6 gene polymorphisms with sodium valproate-induced tremor in patients with epilepsy.

机构信息

Qinghai University Graduate School, Xining, China.

Department of Neurology, Qinghai Provincial People's Hospital, Xining, China.

出版信息

Seizure. 2024 Aug;120:56-60. doi: 10.1016/j.seizure.2024.06.008. Epub 2024 Jun 14.

DOI:10.1016/j.seizure.2024.06.008
PMID:38908142
Abstract

BACKGROUND

Individual susceptibility to sodium valproate (VPA)-induced tremors may be due to genetic polymorphisms in the gene encoding the uridine diphosphate glucuronosyltransferase (UGT) enzyme, which affec the drug's clinical efficacy and cause toxic side effects. This study aimed to investigate the association between UGT1A6 polymorphisms and VPA-induced tremors in patients with epilepsy.

METHODS

In total, 128 patients with epilepsy were enrolled. Patients with epilepsy who received VPA were divided into tremor and non-tremor groups. Polymerase chain reaction-restriction fragment length polymorphism was used to investigate the genotype of UGT1A6 polymorphisms.

RESULTS

Carriers of the UGT1A6 A541G mutant genotype conferred a higher risk of tremor than wild-type carriers (odds ratio 2.128, P = 0.045). Logistic regression analysis showed that the A541G mutant genotype was a significant genetic risk factor for VPA-induced tremors. This suggests that individual susceptibility to VPA-induced tremors may result, at least partially, from genetic variation in UGT1A6 A541G.

CONCLUSIONS

Patients with epilepsy carrying the UGT1A6 A541G mutant genotype may have VPA-induced tremors, and early detection of this genotype will help guide the clinical individualizsation of VPA treatment.

摘要

背景

个体对丙戊酸钠(VPA)引起的震颤的易感性可能是由于编码尿苷二磷酸葡萄糖醛酸基转移酶(UGT)酶的基因中的遗传多态性所致,这会影响药物的临床疗效并引起毒性副作用。本研究旨在探讨 UGT1A6 多态性与癫痫患者 VPA 诱导的震颤之间的关系。

方法

共纳入 128 例癫痫患者。接受 VPA 治疗的癫痫患者分为震颤组和非震颤组。采用聚合酶链反应-限制性片段长度多态性分析方法研究 UGT1A6 多态性的基因型。

结果

携带 UGT1A6 A541G 突变基因型的患者发生震颤的风险高于野生型携带者(优势比 2.128,P=0.045)。Logistic 回归分析表明,A541G 突变基因型是 VPA 诱导震颤的显著遗传危险因素。这表明,个体对 VPA 诱导的震颤的易感性至少部分是由于 UGT1A6 A541G 的遗传变异引起的。

结论

携带 UGT1A6 A541G 突变基因型的癫痫患者可能会出现 VPA 诱导的震颤,早期检测该基因型有助于指导 VPA 个体化治疗。

相似文献

1
Association of UGT1A6 gene polymorphisms with sodium valproate-induced tremor in patients with epilepsy.UGT1A6 基因多态性与癫痫患者丙戊酸钠诱导性震颤的相关性。
Seizure. 2024 Aug;120:56-60. doi: 10.1016/j.seizure.2024.06.008. Epub 2024 Jun 14.
2
Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy.UGT1A6、UGT2B7 和 CYP2C9 基因型对中国癫痫儿童丙戊酸血药浓度的影响。
Drug Metab Pharmacokinet. 2012;27(5):536-42. doi: 10.2133/dmpk.dmpk-11-nt-144.
3
Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy.UGT1A6 和 UGT2B7 基因多态性的分布模式及其对丙戊酸和卡马西平药代动力学的影响:在巴基斯坦癫痫患者中进行的前瞻性遗传关联研究。
Gene. 2024 Jan 20;892:147886. doi: 10.1016/j.gene.2023.147886. Epub 2023 Oct 10.
4
Prevalence of UGT1A6 polymorphisms in children with epilepsy on valproate monotherapy.接受丙戊酸单药治疗的癫痫儿童中UGT1A6基因多态性的患病率。
Neurol India. 2015 Jan-Feb;63(1):35-9. doi: 10.4103/0028-3886.152631.
5
Impact of MDR1 and UGT Gene Polymorphisms on Sodium Valproate Plasma Concentration in Patients with Epilepsy.MDR1 和 UGT 基因多态性对癫痫患者丙戊酸钠血药浓度的影响。
Clin Lab. 2022 Oct 1;68(10). doi: 10.7754/Clin.Lab.2022.220101.
6
CYP2C19 & UGT1A6 genetic polymorphisms and the impact on Valproic acid-induced weight gain in people with epilepsy: Prospective genetic association study.CYP2C19和UGT1A6基因多态性及其对癫痫患者丙戊酸所致体重增加的影响:前瞻性基因关联研究
Epilepsy Res. 2021 Nov;177:106786. doi: 10.1016/j.eplepsyres.2021.106786. Epub 2021 Oct 7.
7
The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach.尿苷二磷酸葡萄糖醛酸转移酶 1A6(UGT1A6)基因多态性对印度癫痫患者丙戊酸药代动力学的影响:一项遗传药理学方法。
Mol Diagn Ther. 2013 Oct;17(5):319-26. doi: 10.1007/s40291-013-0041-8.
8
Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.尿苷二磷酸葡萄糖醛酸基转移酶2B7 -161C>T基因多态性对小儿癫痫患者丙戊酸浓度的影响。
Ther Drug Monit. 2014 Jun;36(3):406-9. doi: 10.1097/FTD.0000000000000012.
9
Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.UDP-葡萄糖醛酸转移酶多态性对中国癫痫患者丙戊酸药代动力学的影响。
Eur J Clin Pharmacol. 2012 Oct;68(10):1395-401. doi: 10.1007/s00228-012-1277-7. Epub 2012 Apr 5.
10
Association of UGT1A6 gene polymorphism with clinical outcome in pediatric epileptic patients on sodium valproate monotherapy.UGT1A6 基因多态性与丙戊酸钠单药治疗儿童癫痫患者临床结局的相关性。
Braz J Med Biol Res. 2021 Jun 14;54(9):e11097. doi: 10.1590/1414-431X2021e11097. eCollection 2021.